Elgyfluor (Gel) Instructions for Use
Marketing Authorization Holder
Pierre Fabre Médicament, CJSC (Russia)
Manufactured By
Pierre Fabre Medicament (France)
ATC Code
A01AA30 (Combined drugs for the prevention of caries)
Dosage Form
| Elgyfluor | Gel for sensitive teeth: tube 75 ml |
Dosage Form, Packaging, and Composition
| Gel for sensitive teeth | 1 g |
| Fluorinol | 8.5 mg |
| Chlorhexidine digluconate | 40 mcg |
75 ml – plastic tubes (1) – cardboard packs.
Therapeutic Category
Drug for the prevention of caries for topical application
Properties
Antiseptic agent with a predominantly bactericidal action. Chlorhexidine, depending on the concentration used, exhibits bacteriostatic or bactericidal action against gram-positive and gram-negative bacteria. Bacteriostatic action is manifested at a concentration of 0.01% or less; bactericidal action – at a concentration of 0.01% at a temperature of 22°C (71.6°F) and exposure for 1 minute; fungicidal action at a concentration of 0.05%, temperature of 22°C (71.6°F) and exposure for 10 minutes; virucidal action (against lipophilic viruses) is manifested at a concentration of 0.01-1%.
It acts on bacterial spores only at elevated temperatures. It is stable; after skin treatment, it remains on it in some quantity sufficient to manifest a bactericidal effect. It retains activity (although somewhat reduced) in the presence of blood, pus, various secretions, and organic substances.
It does not have a damaging effect on items made of glass, plastic, and metals.
Scope of Application
As a therapeutic and prophylactic agent for various infections, for aseptic treatment and disinfection.
For external use: treatment of wounds, burn wounds and surfaces; disinfection of the patient’s skin.
For external and local use: bacterial and fungal diseases of the skin and mucous membranes in surgery, urology, obstetrics and gynecology, dentistry (gingivitis, stomatitis, aphthae, periodontitis, alveolitis); prevention of venereal diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis).
For use in dentistry and ENT practice: gingivitis, stomatitis, aphthae, periodontitis, alveolitis, disinfection of removable dentures; angina; postoperative care for patients in ENT and dentistry departments.
For vaginal use: trichomonas colpitis, cervical erosion, vulvar itching, prevention of venereal diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis); prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth, abortion, before and after insertion of an IUD, before and after diathermocoagulation of the cervix, before intrauterine examinations); treatment of bacterial vaginosis, colpitis (including nonspecific, mixed, trichomonas).
Treatment of the surgeon’s hands, medical personnel, and the operating field before diagnostic manipulations and surgery.
Disinfection of working surfaces of instruments (including thermometers) and equipment for which thermal treatment is undesirable.
In the form of an alcohol solution
Hygienic treatment of the hands of medical personnel, surgeons’ hands, for treatment of the skin of the operating and injection fields, the elbow bend of a donor; disinfection of small-area surfaces of medical products, including dental instruments (for which thermal treatment is undesirable) in healthcare facilities. Hygienic hand treatment in healthcare facilities. Hygienic hand treatment of medical personnel in institutions of various profiles and purposes.
ICD codes
| ICD-10 code | Indication |
| A50 | Congenital syphilis |
| A51 | Early syphilis |
| A52 | Late syphilis |
| A54 | Gonococcal infection |
| A56.0 | Chlamydial infections of lower genitourinary tract |
| A56.1 | Chlamydial infections of pelvic organs and other genitourinary organs |
| A59 | Trichomoniasis |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| K04 | Diseases of pulp and periapical tissues (including periodontitis) |
| K05 | Gingivitis and periodontal diseases |
| K10.3 | Alveolitis of jaws |
| K12 | Stomatitis and related lesions |
| L29.2 | Pruritus vulvae |
| N34 | Urethritis and urethral syndrome |
| N37.0 | Urethritis in diseases classified elsewhere |
| N72 | Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis) |
| N76 | Other inflammatory diseases of vagina and vulva |
| N77.1 | Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere |
| N86 | Erosion and ectropion of cervix |
| N89.8 | Other noninflammatory disorders of vagina |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| Z29.8 | Other specified prophylactic measures |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| Z97.2 | Presence of dental prosthesis |
| ICD-11 code | Indication |
| 1A60.Z | Congenital syphilis, unspecified |
| 1A61.Z | Early syphilis, unspecified |
| 1A62.Z | Late syphilis, unspecified |
| 1A7Z | Gonococcal infection, unspecified |
| 1A81.0 | Chlamydial infection of lower genitourinary tract |
| 1A81.1 | Chlamydial infection of internal reproductive organs |
| 1A92 | Trichomoniasis |
| 1F23.10 | Candidiasis of vulva and vagina |
| 1F65 | Enterobiasis |
| 1H0Z | Unspecified infection |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA06.1 | Alveolitis of jaw |
| DA09.Z | Diseases of pulp and periapical tissues, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| GA00 | Vulvitis |
| GA02.Z | Unspecified vaginitis |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| GA15.1 | Erosion or ectropion of cervix |
| GA42.0 | Pruritus vulvae |
| GC02.1 | Nonspecific urethritis |
| GC02.Z | Urethritis and urethral syndrome, unspecified |
| GC42.1 | Painful intercourse |
| MF3A | Vaginal discharge |
| ND56.0 | Superficial injury of unspecified body region |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
| QB51.A | Presence of dental prosthetic device |
| QB9A | Preparatory procedures for subsequent treatment |
| QC05.Z | Prophylactic measures, unspecified |
| 1A94.0 | Genital or urogenital tract infection caused by Herpes simplex virus |
| GA41 | Ulcerative or erosive diseases of vulva |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| XA5WW1 | Cervix uteri |
| GA1Z | Unspecified noninflammatory disorders of female genital tract |
| XA1LK7 | Vagina |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a pea-sized amount of gel to a dry toothbrush.
Brush teeth thoroughly for two minutes twice daily, typically in the morning and evening.
After brushing, spit out the excess gel. Do not rinse your mouth to allow the active ingredients to remain on the teeth.
Avoid eating or drinking for at least 30 minutes after application.
For the management of dentin hypersensitivity, use consistently as part of your daily oral hygiene routine.
For the prevention of caries, ensure the gel contacts all tooth surfaces, paying particular attention to fissures and interdental spaces.
This regimen is intended for long-term use under dental supervision.
Use only for oral hygiene; the gel is not for systemic use.
In case of accidental ingestion of large amounts, seek medical attention immediately.
For children under 12 years of age, use only under the direct guidance of a dentist or physician.
If gingival irritation occurs, discontinue use and consult your dentist.
Side Effects
Depending on the dosage form used, the following side reactions very rarely develop.
Allergic reactions: skin rash, itching, severe allergic reactions, including anaphylaxis.
Skin and subcutaneous tissue disorders: dry skin, itching, dermatitis, photosensitivity.
Local reactions: staining of tooth enamel, tartar deposition, taste disturbance.
With vaginal use, allergic reactions (rash, itching), burning are possible; very rarely – anaphylactic reactions; in some cases – bloody discharge from the vagina.
Contraindications
Hypersensitivity to chlorhexidine.
Use During Pregnancy and Lactation
If it is necessary to use during pregnancy and during breastfeeding, the expected benefit of therapy for the mother and the possible risk to the fetus should be weighed.
Special Instructions
Avoid getting chlorhexidine into the eyes (except for a special dosage form intended for use in ophthalmology), as well as contact with the meninges and the auditory nerve.
With intravaginal use, in case of bloody discharge from the vagina, the use of chlorhexidine should be discontinued.
Drug Interactions
It is used in a neutral environment; at pH 5-8 the difference in activity is small; at pH above 8 a precipitate forms.
It is not used in combination with anionic compounds, including soap.
It is incompatible with carbonates, chlorides, phosphates, borates, sulfates, and citrates.
The use of hard water reduces bactericidal properties.
It is compatible with medicinal products containing a cationic group (benzalkonium chloride, cetrimonium bromide).
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Kagocel pills 12mg, 30pcs
Picamilon pills 50mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Ingavirin capsules 90mg, 10pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Phenibut-Vertex pills 250mg, 20pcs 